Milestone Pharmaceuticals Inc. announced an investor event on February 25, 2025, in New York to discuss its commercial launch plan for etripamil nasal spray, also known as CARDAMYST™, which is ...

and we look forward to sharing a comprehensive update at our investor event on February 25.” FDA Prescription Drug User Fee Act (PDUFA) target date is March 27, 2025. Milestone’s New Drug ...

28, 2025 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc ... and we look forward to sharing a comprehensive update at our investor event on February 25.” CARDAMYST for Paroxysmal ...